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Furosemide has been widely used in sick prematures but its long-term side effects have not been well evaluated. We examined 26 (12 control, C and 14 F) of 30 surviving infants (9250gms) who were included in a previously controlled study. All infants had RDS and required mechan. vent. shortly after birth. Infants in F group were given 1 mg/kg I.V. F shortly after birth (0-8 hrs) and then q 24 hrs for a total of 3 doses. There was no sign. difference hetween C and F infants in B.W. (mean+Sllr 993298 vs 1114+126gms), gest. age (29.19.8 vs 29.15 .5 wks), Apgar score, blood gases 2nd pH before the study. The postconcep. age at time of follow-up for C group was 13. 45 31-P ~'~~' s~e c~o ' s c o~~ allows noni;&asive measure'ments of phosphorus containing oxidative metabolites (ATP), phosphocreatine (PCr), inorganic phosphate (Pi), and phosphorylated monoester (PME). We used 31-P NMR t o study cortical metabolism in 7 asphyxiated infants (mean gestational age (GA) 32 wks, birth weight (BW) 1430 gms). Although they had perinatal asphyxia, their neurolo ic and head ultra sound exams were normal a t the time of spectroscopy ?mean 27 D). One infant (BW I400 gms, GA 30 wks) was studied postmortem. Babies were stabilized in an isolette and placed into a 1.9Tsuperconducting magnet. Four hundred spectra were obtained over 20 min from the left temporal-parietal region. Human newborn cortical 31-P NMR spectra had large amounts of PME (>7m molelkg fw); a high ratio of PMEIATP (1.605.055); low phosphate potential, PCrIPi (2.225.95), pH = 7.12.2. These results differ from newborn gerbils and mature dogs In which PME is small, PMEIATP ".LO, and PCr/Pi ". 7.5. In the postmortem baby, PME was present in equal concentrations, but PCr and ATP had been depleted. We have previously suggested that PME is primarily a sugar phosphate (G-6-P, R-5-P); however, its presence a f t e r death suggests t h a t i t is not metabolically active and probably represents either phosphoryl choline or phosphoryl ethanolamine which may be present for later myelin synthesis. PCr normally serves a s a reservoir for rapid conversion t o ATP; the low PCr concentration in human newborns suggests that they have little metabolic reserve and consequently may be more vulnerable t o cerebral hypoxia/ischemia. ( The occurrence of RLF was investigated on the basis of data collected in a large clinical trial on the management of patent ductus arteriosus in the premature neonate. An unanticipated association was noted between the occurrence of RLF and maternal use of antihistamines during the last two weeks of pregnancy (but not with earlier use). The incidence of RLF (of any grade) was .22 (19186) among the exposed and .ll (32412940) among the non-exposed (pc0.001). This association was not r.onfounded by birthweight or by total amount of oxygen supplementation, as reflected by either duration of ventilatory support or diagnosis of bronchopulmonary dysplasia. In addition, there was no confounding by episodes of exposure to high levels of oxygen concerr tration, as inferred from recorded episodes of apnea or bradycardia. Other medications had been used more often by mothers who had taken antihistamines than by those who had not (74% vs. 50%). None of these other medications, however, were associated with the occurrence of RLF. Indications for antihistamine use could not be examined as potential confounders, as such information had not been recorded.
No prior data directly bearing on a causal connection between antihistamine exposure and RLF have been reported. Biologic insights have not led to postulation of such a connection. Thus, our data, while provocative in raising the suggestion of a causal relation, nevertheless leave it quite uncertain. Neonatal hypertension i s o f t e n a s s o c i a t e d with renal a r t e r y thrombosis a f t e r use o f umbilical a r t e r y c a t h e t e r s . A1 though i n f a n t s with NRH u s u a l l y respond t o medical t h e r a p y , t h e i r progn o s i s i s u n c l e a r ; longtenn followup o f 11 i n f a n t s i s presented.
Mean birthweight was 2914 gm; pre-treatment blood p r e s s u r e , 161/100 mmHg, and age o f o n s e t , 7 . 8 days. 9 o f 11 i n f a n t s had umbilical a r t e r y c a t h e t e r s . A renal abnormality was noted on renal scan o r angiography i n 9 o f 11 i n f a n t s . 7 of 10 i n f a n t s s t u d i e d had e l e v a t e d p e r i p h e r a l plasma r e n i n a c t i v i t y (PRA). All i n f a n t s became normotensive with d i u r e t i c and/or a n t i h y p e r t e n s i v e a g e n t s and remained so when weaned o f f drugs. 2 i n f a n t s died a t 3 months of age of SIDS and pneumonia. The remaining have been followed f o r 5.5 t o 7.5 y e a r s . 2 c h i l d r e n , n e i t h e r small f o r g e s t a t i o n a l age, have h e i g h t s and weights below t h e 5 t h percent i l e f o r age. One c h i l d has a c r e a t i n i n e c l e a r a n c e of 62 mllminl 1.73 m2. PRA i n 8 c h i l d r e n s t u d i e d i s normal. Renal u l t r a s o u n d , intravenous pyelography, and renal scan demonstrate p e r s i s t e n t renal a b n o r m a l i t i e s i n 7 o f 9 c h i l d r e n .
Neonates with NRH responded well t o a n t i h y p e r t e n s i v e medicat i o n , remained normotensive o f f medications, but had s i g n i f i c a n t a b n o r m a l i t i e s i n renal s i z e and f u n c t i o n which p e r s i s t e d o v e r a 6 y e a r period. Because t h e i r u l t i m a t e prognosis i s u n c l e a r , longterm followup o f i n f a n t s with NRH i s i n d i c a t e d . 
I a b s r a t o r y a d h i s t o l o g i c f i n d i n g s a t the time o f b i o p s y were correlated w i t h outcome i n 17 c h i l d r e n w i t h
IgA n e wpathy. E i g h t c h i l d r e n had less t h a n 1 gm o f p r o t e i n u r i a per 24 hrs (P) (group I) and 9 c h i l d r e n more than 1 gm o f P two y e a r s ( r a n g e 1 m t h to 6 y e a r s ) all group I c h i l d r e n have nard r e n a l f u n c t i o n and o n l y one has P > l gm: i n c o n t r a s t , 4 o f 9 o f group I1 c h i l d r e n have d e c r e a s e d r e n a l f u n c t i o n ( 3 r e q u i r e d i a l y s i s ) and 8 o f 9 h a v e -1 gm. We conclude that c h i l d r e n w i t h P> 1 gm a t t h e time o f d i a g n o s i s o f IgA nephrcp a t h y h a v e mre s e v e r e h i s t o l o g i c a l t e r a t i o n s i n c l u d i n g a h i g h frequency o f crescent formation and a g r e a t e r incidence of GBM d e p i t i o n o f IgA. Such c h i l d r e n are a t r i s k to have p e r s i s t e n t p r o t e i n u r i a and to d e v e l o p renal i n s u f f i c i e n c y . Serum and urinary beta 2-microglobulin (B2M) levels were measured by enzyme immunoassay in 28 normal neonates at days 1 to 2 and 3 to 4 of life in relation to gestational age (GA) and postnatal age (PNA). There were 10 preterm (P) and 18 term (T) infants with a mean GA of 34.5 and 39.1 weeks respectively. The serum BzM, glomerular filtration rate (GFR) and filtered load of 62M increased with increasing GA and PNA. No correlation was found between the serum 62M levels and the GFR as measured by endogenous creatinine clearance. Urinary 8 2~ increased with increasing PNA. In both P and T infants the increase in 8zM excretion paralleled an increase in filtered BnM. The 8zM excretion in relation to GA showed a variable response. There was no correlation between serum and urinary B2M levels. Fractional excretion (%FE) 8 2~ decreased as a function of both the CA and the PNA. A significant inverse correlation was found between %FE 62M and GA for infants <37 weeks, (r=O.9716, P<0.005). The fall in %FE BzM reached a plateau at 0.7% by 38 weeks of gestation. The highest %FE 6zM (8.65%) was observed in infants of 32 weeks gestation, yet had the lowest filtered load of the protein. We conclude that 1) serum 82M level is a poor predicator of GFR in neonates <4 days of life. 2) glomerulotubular balance for B2M is established in infants with GA of 37 weeks or more. 3) %FE 82M can be used as a marker to assess the renal functional maturation in neonates in the early days of life.
